Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

Email

Citing NCI Patient-Derived Models and Associated Data

Citing the PDMR as a reference

Use a similar format as that shown below:

The NCI Patient-Derived Models Repository (PDMR), NCI-Frederick, Frederick National Laboratory for Cancer Research, Frederick, MD. URL — https://dctd.cancer.gov/drug-discovery-development/reagents-materials/pdmr

Citing Models in the Methods section

Use the full distribution lot name in the publication (e.g., 123456-001-R, 123456-001-R-J1-PDC), not an abbreviated form. In addition, the Contributor name, the lot# received, and the passage of material used for analysis should be cited. The name of the Contributor for a model is noted at the patient level in the PDMR database. Use a format as shown below:

Models developed by the PDMR:

  • Example: The PDX models 123456-001-R [Lot# AA1111] and 789123-001-R [Lot# BB2222] used in this study were developed by NCI PDMR.

Models developed by Contributing Institutions:

  • Example: The PDX models LG0123-001-R [Lot# AA111] and K12345-001-R [Lot# BB222] used in this study were developed by The Jackson Laboratory (Bar Harbor, ME) and are available from the NCI Patient Derived Models Repository (NCI PDMR; Frederick, MD; https://dctd-cms.cancer.gov/drug-discovery-development/reagents-materials/pdmr).
  • Example: The PDX model K12345-001-R [Lot# AA1111] used in this study was developed by MD Anderson Cancer Center (Houston, TX) and is available from the NCI Patient Derived Models Repository (NCI PDMR; Frederick, MD; https://dctd-cms.cancer.gov/drug-discovery-development/reagents-materials/pdmr).

Any modifications to the distributed model should be identified (e.g., transfection, CRISPR, etc.).

Sequence files downloaded for use in analysis should be referenced including the version# listed in the file name as different pipeline versions may result in different interpretations of the data (e.g., v1.2, v1.3, v2.0.1.51.0).

Please note:

This README file lists previously posted sequence files that should be removed from any subsequent analysis.

If you would like to reproduce some or all of this content, see Reuse of NCI Information for guidance about copyright and permissions. In the case of permitted digital reproduction, please credit the National Cancer Institute as the source and link to the original NCI product using the original product's title; e.g., “Citing NCI Patient-Derived Models and Associated Data was originally published by the National Cancer Institute.”

Email